We can’t find the page you were looking for.
Click the button to go back to the homepage or use the back button on your browser.
References
- SKINVIVE™ by JUVÉDERM® DFU. 20081699. Revision 2023-10-04.
The information on this website is intended for informational and educational purposes only and should not be used as a substitute for advice provided by a qualified aesthetic healthcare professional.
Models received a variety of JUVÉDERM® products, including SKINVIVE™ by JUVÉDERM®. Images provided courtesy of Allergan Aesthetics, an AbbVie company (unless stated otherwise). Actual treatment results may vary. Images are for illustrative purposes only.
Website produced and funded by Allergan Aesthetics, an AbbVie company.
IMPORTANT SAFETY INFORMATION
This content is intended for UK and Irish adult (>18yrs) audiences only. You should always consult a healthcare professional to help you decide if SKINVIVE™ by JUVÉDERM® is right for you and provide you with a full list of potential side effects.
Potential side effects associated with SKINVIVE™ by JUVÉDERM® include temporary injection-site reactions such as redness, swelling, itching, pain, firmness, bumps, bruising, and discolouration. These reactions may occur immediately or may be delayed. As with any injection, there is a risk of infection. This is not a complete list of side effects. If inflammatory reactions persist for more than one week, or if any other side effects develop, seek medical attention as soon as possible.1
Please refer to SKINVIVE by JUVÉDERM® Directions for use (DFU) for a full list of indications, contraindications, precautions for use, and adverse events.
Adverse events should be reported.
Reporting of side effects:
UK patients: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can help by reporting side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. Adverse events should also be reported to AbbVie at ProductSurveillance_EAME@allergan.com. By reporting side effects, you can help provide more information on the safety of this product.
Irish patients: If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via www.hpra.ie.
